LeadIQ logo
Learn more at LeadIQ.com

Insights

Global Expansion Santen Pharmaceutical recently expanded its exclusive development and commercialization agreement with Aerie to target additional territories including Europe, China, and several other regions. This expansion presents new sales opportunities for the company in key global markets.

Innovative Product Launch Santen Inc launched Ducressa, a fixed-dose combination (FDC) of levofloxacin and dexamethasone eye drops designed for the prevention and treatment of inflammation and infection associated with cataract surgery in adults. This innovative product launch opens up avenues for sales growth and market penetration.

Strategic Partnerships Santen Inc has partnered with Harrow Health, Inc., based in the USA, to further expand its product portfolio in the North American market. These strategic partnerships can lead to increased sales channels and distribution networks for Santen Pharmaceutical.

Award Recognition Santen Pharmaceutical Co. will receive the Glaucoma Research Foundation's Catalyst Award, the organization's highest distinction. This recognition can enhance the company's brand reputation and credibility, potentially attracting new sales opportunities and partnerships.

Innovative Sustainability Initiatives Santen Inc has launched the first bio-based plastic eye drop bottle in the Europe, Middle East, and Africa (EMEA) region as part of its zero-carbon commitment. This sustainability-focused innovation can serve as a unique selling point, appealing to environmentally conscious customers and opening doors to new sales markets.

Similar companies to Santen Pharmaceutical

Santen Pharmaceutical Tech Stack

Santen Pharmaceutical uses 8 technology products and services including Microsoft Power BI, OneTrust, Centricity, and more. Explore Santen Pharmaceutical's tech stack below.

  • Microsoft Power BI
    Business Intelligence
  • OneTrust
    Cookie Compliance
  • Centricity
    Customer Service
  • Microsoft Excel
    Editors
  • Veeva Vault
    Enterprise Content Management
  • ServiceNow
    Miscellaneous
  • Combin
    Social Media Marketing Software
  • Adobe Creative Suite
    Visualisation Software

Media & News

Santen Pharmaceutical's Email Address Formats

Santen Pharmaceutical uses at least 1 format(s):
Santen Pharmaceutical Email FormatsExamplePercentage
First.Last@santen.comJohn.Doe@santen.com
97%
FLast@santen.comJDoe@santen.com
2%
First.MiddleLast@santen.comJohn.MichaelDoe@santen.com
1%

Frequently Asked Questions

Where is Santen Pharmaceutical's headquarters located?

Minus sign iconPlus sign icon
Santen Pharmaceutical's main headquarters is located at 4-20 Kita-ku, Ofuka-cho, Osaka 530-8552 JP. The company has employees across 5 continents, including AsiaNorth AmericaEurope.

What is Santen Pharmaceutical's phone number?

Minus sign iconPlus sign icon
You can contact Santen Pharmaceutical's main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Santen Pharmaceutical's official website and social media links?

Minus sign iconPlus sign icon
Santen Pharmaceutical's official website is santen.com and has social profiles on LinkedIn.

How much revenue does Santen Pharmaceutical generate?

Minus sign iconPlus sign icon
As of October 2024, Santen Pharmaceutical's annual revenue reached $750M.

What is Santen Pharmaceutical's SIC code NAICS code?

Minus sign iconPlus sign icon
Santen Pharmaceutical's SIC code is 5122 - Drugs, Drug Proprietaries, and Druggists' Sundries NAICS code is 523920 - Portfolio Management.

How many employees does Santen Pharmaceutical have currently?

Minus sign iconPlus sign icon
As of October 2024, Santen Pharmaceutical has approximately 1.6K employees across 5 continents, including AsiaNorth AmericaEurope. Key team members include Chief Administrative Officer: M. I.Chief Engineer Randd: J. M.Vice President Business Development: C. S.. Explore Santen Pharmaceutical's employee directory with LeadIQ.

What industry does Santen Pharmaceutical belong to?

Minus sign iconPlus sign icon
Santen Pharmaceutical operates in the Pharmaceutical Manufacturing industry.

What technology does Santen Pharmaceutical use?

Minus sign iconPlus sign icon
Santen Pharmaceutical's tech stack includes Microsoft Power BIOneTrustCentricityMicrosoft ExcelVeeva VaultServiceNowCombinAdobe Creative Suite.

What is Santen Pharmaceutical's email format?

Minus sign iconPlus sign icon
Santen Pharmaceutical's email format typically follows the pattern of . Find more Santen Pharmaceutical email formats with LeadIQ.
Santen Pharmaceutical

Santen Pharmaceutical

Pharmaceutical ManufacturingŌsaka, Japan1001-5000 Employees

As a specialized company dedicated to ophthalmology, Santen carries out research, development, marketing, and sales of pharmaceuticals, over-the-counter products, and medical devices. Santen is the market leader for prescription ophthalmic pharmaceuticals in Japan and its products now reach patients in over 60 countries and regions. With scientific knowledge and organizational capabilities nurtured over a 130-year history, Santen provides products and services to contribute to the well-being of patients, their loved ones and consequently to society.

Santen Pharmaceutical Official Social Media Global Terms of Use​
 https://www.santen.com/en/legal/

Section iconCompany Overview

Headquarters
4-20 Kita-ku, Ofuka-cho, Osaka 530-8552 JP
Phone number
Website
santen.com
SIC Code
5122 - Drugs, Drug Proprietaries, and Druggists' Sundries
NAICS Code
523920 - Portfolio Management
Employees
1001-5000

Section iconFunding & Financials

  • $100M$1B

    Santen Pharmaceutical's revenue is in the range of $100M$1B

Section iconFunding & Financials

  • $100M$1B

    Santen Pharmaceutical's revenue is in the range of $100M$1B

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.